PRE PRENETICS GLOBAL LIMITED

Prenetics Announces Participation in December Investor Conferences

Prenetics Announces Participation in December Investor Conferences

CHARLOTTE, N.C., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited, (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announced that members of the Prenetics management team will participate in two upcoming investor conferences.

iAccess Alpha Virtual Best Ideas Winter Conference 2024

Date: December 10-11, 2024

Location: Virtual

Presentation: December 10, 2024 at 10:00am ET

Webcast:

Danny Yeung, Chief Executive Officer, will deliver a presentation on December 10, 2024, and will be joined by Stephen Lo, Chief Financial Officer, and David Vanderveen, President of Prenetics Americas, for one-on-one investor meetings to be held on December 11, 2024.

13th Annual ROTH Deer Valley Event

Date: December 11-13, 2024

Location: Park City, UT

David Vanderveen, President of Prenetics Americas, will be hosting one-on-one investor meetings throughout the conference.

Mr. Vanderveen has had a successful 30-year track record in beverage, nutrition, and technology, leading disruptive change at both Nirvana Water Sciences and XS Worldwide as prior CEO.

For more information or to schedule a meeting with management, please contact the Company’s investor relations at .

About Prenetics

Prenetics (NASDAQ:PRE), a leading health sciences company, is dedicated to advancing consumer and clinical health. Our consumer initiative is led by IM8, a new health and wellness brand and Europa, one of the largest sports distribution companies in the USA. Our clinical division is led by Insighta, our $200 million venture focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for comprehensive genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer comprehensive DNA tests. Each of Prenetics’ units synergistically enhances our global impact on health, embodying our commitment to ‘enhancing life through science’. To learn more about Prenetics, please visit .

Investor Relations Contact:



Angela Cheung

Investor Relations / Corporate Finance

Prenetics Global Limited



EN
04/12/2024

Underlying

PREPRENETICS GLOBAL LIMITED

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on PRENETICS GLOBAL LIMITED

 PRESS RELEASE
Free
PRE PRENETICS GLOBA...

World No. 1 Tennis Star Aryna Sabalenka Joins Prenetics’ IM8 Health as...

World No. 1 Tennis Star Aryna Sabalenka Joins Prenetics’ IM8 Health as Global Ambassador and Shareholder Aryna Sabalenka becomes first-ever current athlete shareholder in Prenetics, listed on the NASDAQ: (PRE)In just six months, IM8 is one of the fastest growing supplement brands in the world, generating an extraordinary US$50m+ Annual Recurring RevenueIM8 has built a loyal customer base of 60,000+ users who have consumed over 5 million servingsIM8, co-founded by David Beckham is available at CHARLOTTE, N.C., June 26, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a le...

June 26, 2025 1 EN
 PRESS RELEASE
Free
PRE PRENETICS GLOBA...

Prenetics Becomes First Healthcare Company to Execute Aggressive Bitco...

Prenetics Becomes First Healthcare Company to Execute Aggressive Bitcoin Treasury Strategy, Secures $20M in BTC, Appoints Former OKEx COO to Board -  Prenetics adopts proven corporate Bitcoin strategy inspired by MicroStrategy's ~$40B Bitcoin holdings and Metaplanet's meteoric treasury transformation -  Following strategic divestiture, Prenetics leverages strengthened $117M balance sheet to execute comprehensive Bitcoin strategy with board-approved majority allocation, institutional financing partnerships, and alpha-generating initiatives. CHARLOTTE, N.C., June 18, 2025 (GLO...

June 18, 2025 1 EN
 PRESS RELEASE
Free
PRE PRENETICS GLOBA...

Prenetics Divests ACT Genomics to Delta Electronics as Part of up to U...

Prenetics Divests ACT Genomics to Delta Electronics as Part of up to US$71.78 Million Transaction Bolsters Prenetics’ pro-forma cash reserves to approximately US$86 million, and pro-forma cash and short-term assets to approximately US$117 millionPrenetics simplifies investment thesis as company focuses on high-growth consumer health brands IM8, CircleDNA, and EuropaPrenetics raised its FY2025 outlook to be US$80 – US$100 million from $73 – US$85 million, driven by the growth of IM8 CHARLOTTE, N.C., June 18, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics”), a ...

June 18, 2025 1 EN
 PRESS RELEASE
Free
PRE PRENETICS GLOBA...

Prenetics Announces First Quarter 2025 Financial Results, Raises FY202...

Prenetics Announces First Quarter 2025 Financial Results, Raises FY2025 Outlook, & Crypto Strategy Announcement Soon Revenue grew 336.5% to $14.4 million from prior year (excluding ACT Genomics)Raises full year revenue outlook to $80 - $100 million (excluding ACT Genomics)IM8 contributed $5.7 million in Q1, with $2.8 million in March alone & provides Q2 revenue projectionsIM8 has more than 55,000 customers with 4.9 million servings delivered and countingDetails of crypto strategy and Bitcoin adoption to be announced soon as part of innovative treasury approach CHARLOTTE, N.C., Ju...

June 12, 2025 1 EN
 PRESS RELEASE
Free
PRE PRENETICS GLOBA...

IM8 Vibrante Miami: Fueling Wellness and Innovation with a Star-Studde...

IM8 Vibrante Miami: Fueling Wellness and Innovation with a Star-Studded Event David Beckham was Joined by Dr. Amy Shah, Dr. Jeremy London, Dr. James DiNicolantonio and Kendal Toole to Reinforce IM8’s Vision for Elite Wellness Accessible to All CHARLOTTE, N.C., April 09, 2025 (GLOBE NEWSWIRE) -- On Monday, , the premium supplement brand co-founded by , hosted IM8 Vibrante - A Celebration of Science, Wellness & Flavor, a memorable evening at the iconic on Miami Beach. In attendance were nearly 150 wellness influencers, creators, science and medical advisors, and media members to celebrate...

April 9, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch